Invasive breast cancer is breast cancer that has spread from its original site into surrounding breast tissue. It represents the majority of new breast cancer diagnoses and is a major contributor to cancer burden among women.
Estrogen-only hormone replacement therapy after risk-reducing bilateral oophorectomy was associated with lower breast cancer risk in women with BRCA1 pathogenic variants. In 919 women followed for an average of 8.8 years, incident breast cancer was lower among HRT users than nonusers.
Recent research explores plant-based diets' association with breast cancer risk, disparities in care for Black women in Canada, and survival outcomes for young women with breast cancer in Latin America.
Innovent Biologics has dosed the first participant in its pivotal Phase 3 HeriCare-Breast01 study evaluating IBI354, a HER2-targeted antibody-drug conjugate, as first-line treatment for unresectable locally advanced or metastatic HER2-positive breast cancer.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07421479 |
Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01) |
ACTIVE_NOT_RECRUITING | |
| NCT07260188 |
Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy |
RECRUITING | |
| NCT06926543 |
Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy |
RECRUITING | PHASE3 |
| NCT06677944 |
Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer |
RECRUITING | PHASE2 |
| NCT06357338 |
Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma |
ENROLLING_BY_INVITATION | |
| NCT06328465 |
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases |
RECRUITING | NA |
| NCT06283511 |
Evaluation of the RESTART Survival Programme |
NOT_YET_RECRUITING | |
| NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
RECRUITING | PHASE2 |
| NCT06158217 |
Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer |
UNKNOWN | |
| NCT05795101 |
TRUDI: TDXD+Durva in HER2+/Low IBC |
RECRUITING | PHASE2 |
